Work

Multimodal Approach Predicts Relapse upon Cessation of Immune Checkpoint Inhibitors in Advanced Melanoma

Year: 2025

Type: article

Study design: Observational Study

Source: Clinical Cancer Research

DOI: 10.1158/1078-0432.ccr-25-0889

Authors: Ka-Won Noh, Yuri Tolkach, Doris Helbig, Vincenzo Mitchell Barroso, Yannick Foerster, Max Schlaak, Tilo Biedermann, Reinhard Buettner, Oana-Diana Persa

Institutions: University of Cologne, University Hospital Cologne, Technical University of Munich, Humboldt-Universität zu Berlin, Charité - Universitätsmedizin Berlin, TUM Klinikum

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Deutsche Forschungsgemeinschaft, Bundesministerium für Bildung und Forschung, Deutsche Krebshilfe, European Regional Development Fund

Award: G914607095

OpenAlex ID: W4413572849

FWCI: 1.085

Cites: 55

Cited by: 3

Related to: 10